Stay updated on Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page
- Check6 days agoChange DetectedThe history shows a new site revision, v3.4.2, replacing the previous v3.4.1 notice about government funding and operating status. The old funding-status notice has been removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check13 days agoChange DetectedAdded a site-wide notice about government funding and updated the revision to v3.4.1. Removed the previous revision entry v3.4.0.SummaryDifference0.5%

- Check20 days agoChange DetectedNew UI elements are added: a glossary toggle and color-coded indicators for additions and deletions in the record history. The revision label updates from v3.3.4 to v3.4.0 and a No FEAR Act Data line is now shown.SummaryDifference0.7%

- Check34 days agoChange DetectedThe Record History shows a new revision entry (v3.3.4) and a prior revision (v3.3.3) in the history log. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedVersion 3.3.3 (2025-12-19) adds Contacts/Locations and Study Status. The preceding Version 3.3.2 (2025-10-06) removes HHS Vulnerability Disclosure.SummaryDifference0.5%

- Check85 days agoChange DetectedThe page history shows a new revision entry, updating from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page.